The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit

The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit

Real-Time OneStep RT-PCR based assay system for detection of SARS-CoV-2


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
L/C,T/T
Production method
Available
Shipping / Lead Time
Negotiable / Negotiable
Keyword
pcr test kit, solgent, covid-19, sars-cov-2
Category
Medical Test Kit
tK Meet
tK Meet

Apply a video call to the Supplier

SEND TO SUPPLIER INQUIRY

EC Corporation

Membership
PRO
Country / Year Established
South Korea South Korea / 2015
Business type
Distributor
Verified Certificate

4

DUNS

Product name The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit Certification FDA , CE
Category Medical Test Kit Material -
Keyword pcr test kit , solgent , covid-19 , sars-cov-2 Unit Size 60.0 * 95.0 * 55.0 mm
Brand name - Unit Weigh -
origin South Korea Stock 0
Supply type Available HS code 3822001020

Product Information

The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS- CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid- turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. 

- PCRC is included
- The LoD(Limit of Detection) : 200 copies/mL
- High specificity (Not detect viruses and bacteria other than the SARS-CoV-2)

The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS- CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid- turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. 

 

The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures. 

 

“DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit” are being exported to more than 60 countries including the U.S.A, Europe and the Middle East. 

 

Certificates: MFDS EUA, FDA EUA, CE IVD marked, Canada I.O etc. 

 

35 CE marked products and RUO diagnostic products Including tuberculosis, sexually transmitted diseases, pneumonia, etc. 

 

ISO 13485:2016, ISO 9001:2015, KGMP 

 

Product Info Attached File

SQD52-K100_Catalog_20210409.pdf

Verified Certificate

FDA

CE

B2B Trade

Price (FOB) Negotiable transportation Express
MOQ Negotiable Leadtime Negotiable
Payment Options L/C,T/T Shipping time Negotiable

EC Corporation

Country / Year Established
South Korea South Korea / 2015
Membership
PRO
Business type
Distributor

4

DUNS

President
Baek Doo Won
Address
705 Yangwharo 161, Mapo-gu, Seoul, Korea
Product Category
Face Shield,Medical Face Mask,Medical Test Kit,Surgical Glove,Surgical Gown
Year Established
2015
Company introduction

EC Corporation is a global distributor that carries diagnosis kit, protective gear, sterilization

equipment and more for current COVID-19 pandemic.

Main Markets

Saudi Arabia Saudi Arabia

U.A.E. U.A.E.

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My tK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more